280 related articles for article (PubMed ID: 21610141)
1. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Lea S; Harbron C; Khan N; Booth G; Armstrong J; Singh D
Br J Clin Pharmacol; 2015 May; 79(5):756-66. PubMed ID: 25358442
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
Higham A; Lea S; Ray D; Singh D
J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
[TBL] [Abstract][Full Text] [Related]
4. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
Kent LM; Smyth LJ; Plumb J; Clayton CL; Fox SM; Ray DW; Farrow SN; Singh D
J Pharmacol Exp Ther; 2009 Feb; 328(2):458-68. PubMed ID: 19004925
[TBL] [Abstract][Full Text] [Related]
6. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
[TBL] [Abstract][Full Text] [Related]
7. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.
Bhavsar P; Khorasani N; Hew M; Johnson M; Chung KF
Eur Respir J; 2010 Apr; 35(4):750-6. PubMed ID: 19840967
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.
Ratcliffe MJ; Dougall IG
BMC Pharmacol Toxicol; 2012 Nov; 13():15. PubMed ID: 23148608
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.
Southworth T; Metryka A; Lea S; Farrow S; Plumb J; Singh D
Br J Pharmacol; 2012 Aug; 166(7):2070-83. PubMed ID: 22352763
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation.
Hoogendijk AJ; Pinhanços SS; van der Poll T; Wieland CW
Immunobiology; 2013 Apr; 218(4):435-42. PubMed ID: 22727776
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.
Armstrong J; Sargent C; Singh D
Clin Exp Immunol; 2009 Oct; 158(1):74-83. PubMed ID: 19737233
[TBL] [Abstract][Full Text] [Related]
13. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
Khalaf RM; Lea SR; Metcalfe HJ; Singh D
Respir Res; 2017 Apr; 18(1):61. PubMed ID: 28420398
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
Smith SJ; Fenwick PS; Nicholson AG; Kirschenbaum F; Finney-Hayward TK; Higgins LS; Giembycz MA; Barnes PJ; Donnelly LE
Br J Pharmacol; 2006 Oct; 149(4):393-404. PubMed ID: 16953188
[TBL] [Abstract][Full Text] [Related]
16. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
Yasui H; Hideshima T; Ikeda H; Jin J; Ocio EM; Kiziltepe T; Okawa Y; Vallet S; Podar K; Ishitsuka K; Richardson PG; Pargellis C; Moss N; Raje N; Anderson KC
Br J Haematol; 2007 Feb; 136(3):414-23. PubMed ID: 17173546
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
Page TH; Brown A; Timms EM; Foxwell BM; Ray KP
Arthritis Rheum; 2010 Nov; 62(11):3221-31. PubMed ID: 20589681
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
Knobloch J; Hag H; Jungck D; Urban K; Koch A
Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone and p38 MAPK inhibition of cytokine production from human lung fibroblasts.
Higham A; Singh D
Fundam Clin Pharmacol; 2021 Aug; 35(4):714-724. PubMed ID: 33145838
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of interleukin-13 production by granulocyte-macrophage colony-stimulating factor-dependent macrophages via protease-activated receptor-2.
Yamaguchi R; Yamamoto T; Sakamoto A; Ishimaru Y; Narahara S; Sugiuchi H; Hirose E; Yamaguchi Y
Blood Cells Mol Dis; 2015 Jun; 55(1):21-6. PubMed ID: 25976462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
